IM Cannabis Corp. (NASDAQ:IMCC) Short Interest Down 55.6% in February

IM Cannabis Corp. (NASDAQ:IMCC) was the recipient of a significant decrease in short interest in February. As of February 27th, there was short interest totaling 8,530 shares, a decrease of 55.6% from the February 12th total of 19,228 shares. Based on an average daily volume of 65,424 shares, the short-interest ratio is currently 0.1 days. Currently, 0.1% of the company’s shares are sold short. Currently, 0.1% of the company’s shares are sold short. Based on an average daily volume of 65,424 shares, the short-interest ratio is currently 0.1 days.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Heron Bay Capital Management bought a new stake in shares of IM Cannabis during the second quarter worth $195,000. DRW Securities LLC bought a new stake in IM Cannabis in the 4th quarter valued at $32,000. Yorkville Advisors Global LP bought a new stake in IM Cannabis in the 3rd quarter valued at $1,452,000. Finally, Hidden Cove Wealth Management LLC acquired a new position in IM Cannabis in the 3rd quarter worth $27,000. Institutional investors own 7.68% of the company’s stock.

IM Cannabis Stock Down 2.2%

Shares of NASDAQ:IMCC traded down $0.02 during trading on Friday, hitting $0.90. 7,321 shares of the company’s stock traded hands, compared to its average volume of 47,745. The company has a current ratio of 0.82, a quick ratio of 0.56 and a debt-to-equity ratio of 0.25. The company has a 50-day moving average price of $1.12 and a 200-day moving average price of $1.51. IM Cannabis has a 52 week low of $0.65 and a 52 week high of $7.12. The company has a market cap of $5.30 million, a price-to-earnings ratio of -1.15 and a beta of 2.17.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of IM Cannabis in a research report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.

IM Cannabis Company Profile

IM Cannabis Corp is a vertically integrated medical cannabis company based in Israel, specializing in the research, cultivation and production of cannabis-based formulations. The company holds three key licenses granted by the Israeli Ministry of Health, covering cultivation, possession and distribution of medical-grade cannabis. Its production facilities in Moshav Yizrael feature controlled-environment agriculture chambers designed to deliver consistent, high-purity cannabinoid profiles.

The company’s product portfolio includes standardized cannabis oils, distillates, vaporizer cartridges and topical preparations, all formulated under Good Manufacturing Practice (GMP) standards.